(Q53289548)

13 May 2018

title

Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis. (English)

1 reference

13 May 2018

author name string

Nicole Mittmann

1

1 reference

13 May 2018

Sandra R Knowles

2

1 reference

13 May 2018

Manuel Gomez

3

1 reference

13 May 2018

Joel S Fish

4

1 reference

13 May 2018

Robert Cartotto

5

1 reference

13 May 2018

Neil H Shear

6

1 reference

13 May 2018

publication date

1 January 2004

1 reference

13 May 2018

published in

Drug Safety

1 reference

13 May 2018

volume

27

1 reference

13 May 2018

issue

7

1 reference

13 May 2018

page(s)

477-487

1 reference

13 May 2018

Principles of Signal Detection in Pharmacovigilance

cites work

1 reference

12 December 2020

Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids

1 reference

12 December 2020

Toxic epidermal necrolysis

1 reference

12 December 2020

Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients

1 reference

12 December 2020

Cutaneous reactions to anticonvulsants

1 reference

12 December 2020

1 reference

12 December 2020

Under-reporting of adverse drug reactions in general practice

1 reference

12 December 2020

Epidemiology of drug-induced severe skin reactions

1 reference

12 December 2020

Top 10 reasons for not reporting adverse drug reactions

1 reference

12 December 2020

Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany

1 reference

12 December 2020

Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system

1 reference

12 December 2020

Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone

1 reference

12 December 2020

The Role of the WHO Programme on International Drug Monitoring in Coordinating Worldwide Drug Safety Efforts

1 reference

12 December 2020

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

1 reference

12 December 2020

Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group

1 reference

12 December 2020

Management of drug-induced toxic epidermal necrolysis

1 reference

12 December 2020

The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients

1 reference

12 December 2020

Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985

1 reference

12 December 2020

Toxic epidermal necrolysis: a review.

1 reference

12 December 2020

Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems

1 reference

12 December 2020

European network for the case-population surveillance of rare diseases (Euronet). A prospective feasibility study.

1 reference

12 December 2020

Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysis

1 reference

12 December 2020

Rhode Island physicians' recognition and reporting of adverse drug reactions

1 reference

12 December 2020

Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas

1 reference

12 December 2020

Toxic epidermal necrolysis. A step forward in treatment

1 reference

12 December 2020

Toxic epidermal necrolysis

1 reference

12 December 2020

Severe adverse cutaneous reactions to drugs

1 reference

12 December 2020

A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century

1 reference

12 December 2020

10.2165/00002018-200427070-00004

Identifiers

DOI

1 reference

13 May 2018

Dimensions Publication ID

1046928977

0 references

1 reference

13 May 2018